NYSE:WST West Pharmaceutical Services (WST) Stock Price, News & Analysis $316.86 +0.73 (+0.23%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$316.32 -0.54 (-0.17%) As of 05/22/2026 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About West Pharmaceutical Services Stock (NYSE:WST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get WST alerts:Sign Up Key Stats Today's Range$311.07▼$317.7950-Day Range$231.24▼$326.1252-Week Range$203.74▼$330.88Volume533,752 shsAverage Volume877,515 shsMarket Capitalization$22.39 billionP/E Ratio42.36Dividend Yield0.28%Price Target$322.89Consensus RatingModerate Buy Company Overview West Pharmaceutical Services, Inc. is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations. In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle. Its offerings include stoppers and seals, custom-molded polymer parts, prefillable syringe systems and a range of delivery device technologies for self-administration. The company also offers development assistance, analytical testing, regulatory support and contract manufacturing, helping customers take complex parenteral products from design through commercial production while meeting stringent quality and compliance requirements. West serves a global customer base that includes large pharmaceutical companies, emerging biotech firms and contract development and manufacturing organizations. The company operates manufacturing, research and development, and quality centers across multiple regions to support international supply chains and regulatory markets in North America, Europe, Asia-Pacific and Latin America. With an emphasis on innovation and quality control, West positions itself as a partner for customers seeking reliable containment and delivery solutions for advanced injectable therapies.AI Generated. May Contain Errors. Read More West Pharmaceutical Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreWST MarketRank™: West Pharmaceutical Services scored higher than 77% of companies evaluated by MarketBeat, and ranked 136th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.6 / 5Analyst RatingModerate Buy Consensus RatingWest Pharmaceutical Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 2 strong buy ratings, 7 buy ratings, 3 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for West Pharmaceutical Services is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageWest Pharmaceutical Services has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about West Pharmaceutical Services' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.47% Earnings GrowthEarnings for West Pharmaceutical Services are expected to grow by 10.47% in the coming year, from $8.60 to $9.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of West Pharmaceutical Services is 39.70, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.02.Price to Earnings Ratio vs. SectorThe P/E ratio of West Pharmaceutical Services is 39.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.06.Price to Earnings Growth RatioWest Pharmaceutical Services has a PEG Ratio of 2.65. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioWest Pharmaceutical Services has a P/B Ratio of 7.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about West Pharmaceutical Services' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.45% of the float of West Pharmaceutical Services has been sold short.Short Interest Ratio / Days to CoverWest Pharmaceutical Services has a short interest ratio ("days to cover") of 2.06, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in West Pharmaceutical Services has recently decreased by 8.89%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldWest Pharmaceutical Services has a dividend yield of 0.28%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthWest Pharmaceutical Services does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of West Pharmaceutical Services is 11.76%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 9.26% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.Read more about West Pharmaceutical Services' dividend. News and Social Media3.8 / 5News Sentiment1.01 News SentimentWest Pharmaceutical Services has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for West Pharmaceutical Services this week, compared to 6 articles on an average week.Search InterestOnly 6 people have searched for WST on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows2 people have added West Pharmaceutical Services to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, West Pharmaceutical Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,129,149.00 in company stock.Percentage Held by Insiders0.60% of the stock of West Pharmaceutical Services is held by insiders.Percentage Held by Institutions93.90% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about West Pharmaceutical Services' insider trading history. Receive WST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WST Stock News HeadlinesWest Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 22 at 2:14 AM | americanbankingnews.comQ1 earnings recap: West Pharmaceutical Services (NYSE:WST) tops drug development inputs & services stocksMay 21 at 1:35 PM | msn.comJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.May 24 at 1:00 AM | Brownstone Research (Ad)West Pharmaceutical Services just got hit by a cyberattack and triggered its incident response — the maker of components for insulin pens and vaccine vialsMay 20, 2026 | msn.comWest Pharma says fully operational after cyberattack, sees no hit to 2026 forecastMay 20, 2026 | reuters.comWest Pharmaceutical Services (NYSE:WST) Upgraded at Zacks ResearchMay 16, 2026 | americanbankingnews.comWest Pharma says operations recovering after cyberattackMay 15, 2026 | reuters.comInsider Selling: West Pharmaceutical Services (NYSE:WST) CAO Sells 896 Shares of StockApril 30, 2026 | insidertrades.comSee More Headlines WST Stock Analysis - Frequently Asked Questions How have WST shares performed this year? West Pharmaceutical Services' stock was trading at $275.53 at the beginning of 2026. Since then, WST stock has increased by 15.0% and is now trading at $316.8550. How were West Pharmaceutical Services' earnings last quarter? West Pharmaceutical Services, Inc. (NYSE:WST) announced its earnings results on Thursday, April, 23rd. The medical instruments supplier reported $2.13 earnings per share for the quarter, topping analysts' consensus estimates of $1.68 by $0.45. The company's revenue was up 21.0% on a year-over-year basis. Read the conference call transcript. How will West Pharmaceutical Services' stock buyback program work? West Pharmaceutical Services' Board of Directors authorized a stock buyback plan on Tuesday, February 17th 2026, which authorizes the company to buy back $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 5.6% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's leadership believes its stock is undervalued. Does West Pharmaceutical Services have any subsidiaries? The following companies are subsidiaries of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., The Tech Group Inc., Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), TGPR Holdings Limited, WD SG Pte. Ltd., and more. Who are West Pharmaceutical Services' major shareholders? Top institutional investors of West Pharmaceutical Services include Bank of New York Mellon Corp (3.49%), Amundi (0.91%), Epoch Investment Partners Inc. (0.77%) and Sei Investments Co. (0.75%). Insiders that own company stock include Eric Mark Green, Thomas W Hofmann, Quintin J Lai, Annette F Favorite, Bernard Birkett, Cindy Reiss-Clark, Silji Abraham, Chad Winters and Charles Witherspoon. View institutional ownership trends. How do I buy shares of West Pharmaceutical Services? Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of West Pharmaceutical Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that West Pharmaceutical Services investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Home Depot (HD), Chevron (CVX) and Netflix (NFLX). Company Calendar Last Earnings4/23/2026Record date for 5/6 Dividend4/29/2026Ex-Dividend for 5/6 Dividend4/29/2026Dividend Payable5/06/2026Today5/24/202646th Annual William Blair Growth Stock Conference6/02/2026Next Earnings (Estimated)7/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 WST's financial health is in the Green zone, according to TradeSmith. WST has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED/DENTAL - SUPP Sub-IndustryHealth Care Supplies Current SymbolNYSE:WST CIK105770 Webwww.westpharma.com Phone(610) 594-2900Fax800-345-9800Employees10,800Year Founded1923Price Target and Rating Average Price Target for West Pharmaceutical Services$322.89 High Price Target$350.00 Low Price Target$295.00 Potential Upside/Downside+1.9%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)$7.48 Trailing P/E Ratio42.36 Forward P/E Ratio36.84 P/E Growth2.65Net Income$493.70 million Net Margins16.85% Pretax Margin20.82% Return on Equity19.03% Return on Assets14.06% Debt Debt-to-Equity Ratio0.07 Current Ratio2.71 Quick Ratio2.04 Sales & Book Value Annual Sales$3.07 billion Price / Sales7.28 Cash Flow$9.75 per share Price / Cash Flow32.50 Book Value$42.33 per share Price / Book7.49Miscellaneous Outstanding Shares70,650,000Free Float70,224,000Market Cap$22.39 billion OptionableOptionable Beta1.17 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSE:WST) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share West Pharmaceutical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
